<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151536">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02123589</url>
  </required_header>
  <id_info>
    <org_study_id>West ChinaH Sedation</org_study_id>
    <nct_id>NCT02123589</nct_id>
  </id_info>
  <brief_title>The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill Adults.</brief_title>
  <official_title>The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill adults-a Prospective, Randomized and Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was designed to explore the  effects of different sedation protocol on incidence
      rates of delirium and PTSD in severe patients with mechanically  ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The incident rate of delirium</measure>
    <time_frame>From weaning to discharged from ICU,about 7 days.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>The incident rates of PTSD</measure>
    <time_frame>30th day and 180th  day after discharged from  ICU</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>The  duration of delirium</measure>
    <time_frame>From weaning to discharged from ICU,about 7 days.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of unexpected extubation</measure>
    <time_frame>From intubation to weaning,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of analgesics and sedatives</measure>
    <time_frame>From intination of analgesics and sedatives to  stopping drug appication,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The duration of mechanical ventilation</measure>
    <time_frame>From intubation to weaning,about 7days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU</measure>
    <time_frame>From admitted to ICU to discharged from ICU,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The whole hospitalization time</measure>
    <time_frame>From  admitted to hospital to discharged from hospital,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' death rates within ICU stay</measure>
    <time_frame>From admitted to ICU to discharged from ICU,about 7  days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' death rates within hospitalized stay</measure>
    <time_frame>From admitted to hospital to discharged from hospital,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cost in ICU</measure>
    <time_frame>From admitted to ICU to discharged from ICU,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total cost in hospital</measure>
    <time_frame>From admitted to hospital to discharged  from hospital,about 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sedative Withdrawal Delirium</condition>
  <arm_group>
    <arm_group_label>Deep sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of 0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion  0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -5 and  -3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep and daily interruption of sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of 0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion  0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -5 and  -3.and from the second day after subject was admitted in ICU, daily interruption of sedation will be taken .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Light sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of 0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion  0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -2 and +1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deep sedation(midazolam and fentanyl )</intervention_name>
    <description>0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl,continuous intravenous infusion ; the target level of sedation,RASS score between -5 and  -3</description>
    <arm_group_label>Deep sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deep and daily interruption of sedation(midazolam and fentanyl )</intervention_name>
    <description>0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl continuous intravenous infusion  ; The target level of sedation,RASS score between -5 and -3. Daily interruption of sedation will be taken from  the second day after admitted in ICU</description>
    <arm_group_label>Deep and daily interruption of sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Light sedation(midazolam and fentanyl )</intervention_name>
    <description>0.05~0.1mg/kg midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h midazolam and1~2μg/kg.h fentanyl,continuous intravenous infusion ; The target level of sedation,RASS score between -2 and +1;</description>
    <arm_group_label>Light sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Critically ill adults whose expected time of mechanical ventilation is longer than 24
             hours

          -  Aged between 18 years old to 85 years old.

        Exclusion Criteria:

          -  Subjects with brain injury;

          -  History of cardiopulmonary resuscitation;

          -  Mental disability;

          -  Taken neuromuscular blocking drugs;

          -  Inability to exchange;

          -  Contraindicated to midazolam or morphine;

          -  Inconvenience to daily interruption
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Kangyan</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
